TVTX
Travere Therapeutics Inc
$49.41
+0.30% (+$0.15)
Volume
9.07M
52W High
$68.73
52W Low
$22.59
Market Cap
$4.75B
Next Earnings Report
Last Reported
Nov 2, 2026 Missed
Actual: -$0.55
vs. Consensus: -$0.25
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q3 2026
Nov 2, 2026
1-Day:
+0.30%
Q3 2026
Oct 29, 2026
1-Day:
-0.36%
5-Day:
-2.29%
Q2 2026
Aug 4, 2026
1-Day:
+12.03%
Q1 2026
May 4, 2026
1-Day:
-0.24%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $129.7M | +73.4% | 84.1% | -25.0% | -$22.0M |
| Q3'25 | $164.9M | +162.1% | 99.0% | 15.1% | $25.7M |
| Q2'25 | $114.4M | +111.5% | 98.7% | -11.1% | -$12.8M |
| Q1'25 | $81.7M | +97.5% | 94.3% | -52.2% | -$41.2M |
| Q4'24 | $74.8M | +66.0% | 96.6% | -81.2% | -$60.3M |
| Q3'24 | $62.9M | +69.6% | 97.4% | -89.3% | -$54.8M |
| Q2'24 | $54.1M | +68.1% | 77.1% | -123.9% | -$70.4M |
| Q1'24 | $41.4M | -27.4% | 96.4% | -336.5% | -$136.1M |
Company Information
Symbol
TVTX
Company
Travere Therapeutics Inc
Market Cap
$4.75B